Lipid lowering and Alzheimer disease risk: A mendelian randomization study

OBJECTIVE: To examine whether genetic variation affecting the expression or function of lipid‐lowering drug targets is associated with Alzheimer disease (AD) risk, to evaluate the potential impact of long‐term exposure to corresponding therapeutics. METHODS: We conducted Mendelian randomization anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Dylan M., Finan, Chris, Schmidt, Amand F., Burgess, Stephen, Hingorani, Aroon D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944510/
https://www.ncbi.nlm.nih.gov/pubmed/31714636
http://dx.doi.org/10.1002/ana.25642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944510/
https://www.ncbi.nlm.nih.gov/pubmed/31714636
http://dx.doi.org/10.1002/ana.25642

Ejemplares similares